NATCO Pharma stock has declined 34% over six days due to disappointing Q3 FY25 results, including a 37.4% revenue drop and a ...

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...

New Delhi: NATCO Pharma Ltd on Wednesday reported a 37.75 per cent decline in consolidated net profit to Rs 132.4 crore in ...

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

IST, the benchmark BSE Sensex was down by 458.50 points or 0.60%, reaching 75,680.47. The broader NSE Nifty was 165.80 points ...

Natco Pharma Stock Falls: NATCO Pharma’s share price dropped another 10% on Friday following weak earnings for the third ...

The stock plunged 10.80 per cent to hit a day low of Rs 868.25. At this price, it has tumbled 28.63 per cent in two trading ...

NATCO Pharma shares tumbled 10% on Friday, extending a two-day slump to 28% after weak Q3 results and a target price cut by ...

Stock analysts noted Natco Pharma’s missed consensus Q3 estimates on both revenue and Ebitda margin fronts due to lack of ...

Revenue decreased by 37.41% YoY & profit decreased by 37.47% YoY, profit at ₹133 crore and revenue at ₹474.8 crore.

Shares of NATCO Pharma Ltd on Thursday slumped 20 per cent after the firm reported a 37.75 per cent decline in consolidated net profit in the December quarter.      The stock tanked 19.99 per cent to ...